The Present Status of Clofibrate (Atromid-S)

Long-Term Effects of Clofibrate (Atromid-S)

Clofibrate was administered to 45 patients for varying periods of time up to 4 years with no evidence of chronic toxicity. Clofibrate was more effective in lowering serum triglycerides than serum cholesterol, with more than 75% of all patients with elevated triglycerides having at least a 25% reduction in triglycerides, the absolute reduction in triglycerides being directly correlated with pret...

Communications. Action of Atromid-S (clofibrate) on intra-ocular pressure.

CHANGES in the levels of the blood lipids during attacks of acute closed-angle glaucoma were studied by Hanisch, Blumenfeld, and Hegeduis (1966), who found that there was a rise in the concentration of.the non-esterified fatty acids during the attack. Accordingly Orbain, Hanisch, and Vereb (1966) treated this condition with a single dose of 15 g. Atromid-S (clofibrate) and claimed that the atta...

Present status of clofibrate therapy in ophthalmology.

Effects of clofibrate with androsterone (atromid) and without androsterone (atromid-S) on blood platelets and lipids in ischaemic heart disease.

A mixture of androsterone and clofibrate (atromid) lowers the blood cholesterol and triglycerides (Oliver, 1962). Clofibrate without androsterone (atromid-S) appears to have the same effect on the serum lipids (Oliver, 1963; Hellman et al., 1963). Atromid lowers platelet stickiness (Carson et al., 1963a, b) which is increased in patients with ischamic heart disease (McDonald and Edgill, 1957); ...

on the status of mixed methods research in applied linguistics

چکیده ندارد.